MIVIX | VTSAX | MIVIX / VTSAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 24 years | - |
Gain YTD | 15.534 | 18.645 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 429M | 1.72T | 0% |
Annual Yield % from dividends | 0.40 | 1.35 | 30% |
Returns for 1 year | 17.47 | 31.56 | 55% |
Returns for 3 years | 10.37 | 25.35 | 41% |
Returns for 5 years | N/A | 85.68 | - |
Returns for 10 years | N/A | 188.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SNTKX | 26.18 | N/A | N/A |
Steward International Enhanced Index A | |||
FBTAX | 34.26 | -0.05 | -0.15% |
Fidelity Advisor Biotechnology A | |||
PLFIX | 28.11 | -0.06 | -0.21% |
Principal Large Cap S&P 500 Index Inst | |||
AGFGX | 13.10 | -0.06 | -0.46% |
American Century Focused Global Gr R5 | |||
RESCX | 8.73 | -0.05 | -0.57% |
HSBC Radiant US Smaller Companies I |